Excellence driven Pharmaceutical Industry Senior Manager. Knowledge and experience in management and implementation of international multicentric trials from site selection to closing phase ,meeting high scientific standards and GCP requierments. Solid project management and marketing expertise with proven product launch experience across different areas from oncology to vaccines in multinational companies. Highly organized, proactive and results oriented professional with experience in Business Development activities including forecasting and finance management. Effectively maintains close relationships with investigators, KOL’s and business partners. Passionate about clinical research and global drug development, has a strong persevering personality and the ability to perform in highly stressful and demanding environments. Excellent interpersonal and collaborative skills, able to manage cross functional and multicultural teams to successful project delivery
Specialties: Project Management, Clinical Research, Business Development; Brand Management; Marketing Strategy; Digital Marketing & Strategy;
Senior Product Manager Vaccines | HPV, Pediatric & Travel Franchises
Since February 2007
Handles responsibilities for Gardasil (qHPV), Rotateq (vaccine against rotavirus infection), and Vaqta (Hep A). Developed pre launch plan for the new HPV vaccine Gardasil 9. Prepares the marketing plans aligned with corporate strategy and local needs. Defines local brand strategies and tactics. Monitors implementation of brand plans and devises corrective actions whenever necessary to guarantee achievement of sales and profit targets (P&L management). Designs promotional campaigns and communication strategy. Manages approval process of promotional materials from design to archive in articulation with Medical and Regulatory departments (ZINC). Maintains relationships with internal partners, business partners, customers and professional organizations. Manages promotional budgets.
Business Development Manager
January 2003 --- January 2006
Responsible for business planning activities reporting to company Vice President. Responsible for identifying new business opportunities and projects for the Pharma department in order to maximize revenue for the organization. In charge of developing strategic plans, market and competitor analysis, conducted forecasts and profit analyses for new market entries, business cases development and P&L management.
Product Manager Oncology
January 1999 --- January 2002
Invited by Novartis Portugal to join the Marketing team and take the responsibility for the product management in the Oncology Business Unit: market analysis, design and implementation of marketing plans, sales forecast, budget management, training and coaching of sales force team, design of promotional materials and communication strategy. Participation in local and international congresses. Organization of local scientific meetings. During this period was responsible for the pre marketing and launch of two new products (Zometa and Glivec) and management of Femara and Aredia. Zometa (Zoledronic Acid) - bone-targeted therapy for treating bone metastases.. Glivec (Imatinib) - first-line treatment of all phases of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML), and gastrointestinal stromal tumors (GIST).
January 1997 --- January 1999
Joined the team responsible for the kick-off of the Oncology Unit at Sanofi Portugal. Responsible for design and implementation of pre-marketing & launch plan for ELOXATIN (oxaliplatin) – treatment of advanced carcinoma of the colon or rectum. Market and competitor’s analysis, identification of main players in the area. Established contacts and developed relationships with Oncology KOL's.
Clinical Research Associate (CRA)
January 1992 --- January 1997
Member of the Medical Department team of Sanofi Portugal was responsible for management and implementation of international multicentric trials (phase III) in cardiology and neurology, namely CAPRIE study (Clopidogrel vs. Aspirin in patients at risk of ischemic event) with 19000 patients randomized ww and 300 patients enrolled in Portugal.
Responsible for identification and selection of study sites, design of CRFs, informed consent, financial agreement, and management of investigator meetings. Submission of study to ethical committees, contract and informed consent preparation. Responsible for overall monitoring activities, study drug management and accountability, follow up of adverse events. Experience in related audits.
AdaptabilityAnalytical thinkingCommunicativeCollaborationEfficiencyFlexibilityOrganizationProblem solvingResult OrientedIndependence
Business DevelopmentBudgetingClinical monitoringClinical researchClinical SuppliesClinical trial managementClinical trialsCross-functional team leadershipGood Clinical Practice (GCP)Infectious diseasesInformed Consent DocumentsKOL managementMarketingObstetrics and gynecologyoncologyPediatricsProject ManagementTeamworkVaccinesBudget ManagementCardiologyClinical study reportsCompetitive AnalysisGastroenterologyGynecologyMarketing ManagementNeurologyProduct launch
Skills and Expertise
Analytical skills Interact with nurses Interact with physicians Monitor a clinical studyApprove consent documentsCommunicate with investigatorComplete case report form (CRF)Conduct close-out visitsConduct maintenance visitsConduct site initiation Report dataAdverse event reportingAttend investigator meetingContract approvalEstablish relationships with Key Opinion LeadersEstablish professional relationships with partnersManage budgetsManage multiple projects
LEADING PHARMA-Programa de Gestão para a Indústria Farmacêutica in from Católica Lisbon School of Business and Economics in 2014
Master of Business Administration (M.B.A.) in Marketing from Católica Lisbon School of Business and Economics | MBA in 1998
Engineer’s Degree in Chemical Engineering-Biotechnology from Instituto Superior Técnico in 1990